nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—ADRB2—chronic obstructive pulmonary disease	0.23	1	CbGaD
Timolol—Levobunolol—Salbutamol—chronic obstructive pulmonary disease	0.187	0.58	CrCrCtD
Timolol—Bupranolol—Salbutamol—chronic obstructive pulmonary disease	0.136	0.42	CrCrCtD
Timolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0561	0.158	CbGbCtD
Timolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0553	0.156	CbGbCtD
Timolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0425	0.12	CbGbCtD
Timolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0425	0.12	CbGbCtD
Timolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0419	0.118	CbGbCtD
Timolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0419	0.118	CbGbCtD
Timolol—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.014	0.0395	CbGbCtD
Timolol—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.014	0.0395	CbGbCtD
Timolol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0107	0.0301	CbGbCtD
Timolol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0107	0.0301	CbGbCtD
Timolol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00951	0.0268	CbGbCtD
Timolol—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00589	0.0166	CbGbCtD
Timolol—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00503	0.0142	CbGbCtD
Timolol—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00475	0.0134	CbGbCtD
Timolol—Levobunolol—ADRB2—chronic obstructive pulmonary disease	0.000857	0.419	CrCbGaD
Timolol—Bupranolol—ADRB2—chronic obstructive pulmonary disease	0.00062	0.303	CrCbGaD
Timolol—Penbutolol—ADRB2—chronic obstructive pulmonary disease	0.000567	0.277	CrCbGaD
Timolol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00135	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000105	0.00135	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.00135	CcSEcCtD
Timolol—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000104	0.00134	CcSEcCtD
Timolol—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.00134	CcSEcCtD
Timolol—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00133	CcSEcCtD
Timolol—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00133	CcSEcCtD
Timolol—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00133	CcSEcCtD
Timolol—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00133	CcSEcCtD
Timolol—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00133	CcSEcCtD
Timolol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000103	0.00133	CcSEcCtD
Timolol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.00132	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000103	0.00132	CcSEcCtD
Timolol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000103	0.00132	CcSEcCtD
Timolol—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.00132	CcSEcCtD
Timolol—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000101	0.0013	CcSEcCtD
Timolol—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.0013	CcSEcCtD
Timolol—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.0013	CcSEcCtD
Timolol—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000101	0.0013	CcSEcCtD
Timolol—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.0013	CcSEcCtD
Timolol—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.00129	CcSEcCtD
Timolol—Infection—Formoterol—chronic obstructive pulmonary disease	0.000101	0.00129	CcSEcCtD
Timolol—Myalgia—Salbutamol—chronic obstructive pulmonary disease	9.98e-05	0.00128	CcSEcCtD
Timolol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	9.98e-05	0.00128	CcSEcCtD
Timolol—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	9.98e-05	0.00128	CcSEcCtD
Timolol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	9.97e-05	0.00128	CcSEcCtD
Timolol—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	9.95e-05	0.00128	CcSEcCtD
Timolol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	9.94e-05	0.00128	CcSEcCtD
Timolol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	9.94e-05	0.00128	CcSEcCtD
Timolol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	9.94e-05	0.00128	CcSEcCtD
Timolol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	9.92e-05	0.00128	CcSEcCtD
Timolol—Oedema—Montelukast—chronic obstructive pulmonary disease	9.92e-05	0.00128	CcSEcCtD
Timolol—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	9.92e-05	0.00128	CcSEcCtD
Timolol—Discomfort—Salbutamol—chronic obstructive pulmonary disease	9.86e-05	0.00127	CcSEcCtD
Timolol—Infection—Montelukast—chronic obstructive pulmonary disease	9.86e-05	0.00127	CcSEcCtD
Timolol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	9.84e-05	0.00127	CcSEcCtD
Timolol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	9.84e-05	0.00127	CcSEcCtD
Timolol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	9.81e-05	0.00126	CcSEcCtD
Timolol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	9.76e-05	0.00126	CcSEcCtD
Timolol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	9.73e-05	0.00125	CcSEcCtD
Timolol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	9.64e-05	0.00124	CcSEcCtD
Timolol—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	9.57e-05	0.00123	CcSEcCtD
Timolol—Oedema—Salbutamol—chronic obstructive pulmonary disease	9.57e-05	0.00123	CcSEcCtD
Timolol—Infection—Salbutamol—chronic obstructive pulmonary disease	9.5e-05	0.00122	CcSEcCtD
Timolol—Hypotension—Formoterol—chronic obstructive pulmonary disease	9.47e-05	0.00122	CcSEcCtD
Timolol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	9.47e-05	0.00122	CcSEcCtD
Timolol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	9.42e-05	0.00121	CcSEcCtD
Timolol—Shock—Salbutamol—chronic obstructive pulmonary disease	9.41e-05	0.00121	CcSEcCtD
Timolol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	9.38e-05	0.00121	CcSEcCtD
Timolol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	9.29e-05	0.00119	CcSEcCtD
Timolol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	9.25e-05	0.00119	CcSEcCtD
Timolol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	9.25e-05	0.00119	CcSEcCtD
Timolol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	9.23e-05	0.00119	CcSEcCtD
Timolol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	9.23e-05	0.00119	CcSEcCtD
Timolol—Insomnia—Formoterol—chronic obstructive pulmonary disease	9.16e-05	0.00118	CcSEcCtD
Timolol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	9.16e-05	0.00118	CcSEcCtD
Timolol—Anorexia—Salbutamol—chronic obstructive pulmonary disease	9.12e-05	0.00117	CcSEcCtD
Timolol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	9.11e-05	0.00117	CcSEcCtD
Timolol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	9.04e-05	0.00116	CcSEcCtD
Timolol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	9.03e-05	0.00116	CcSEcCtD
Timolol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	9.03e-05	0.00116	CcSEcCtD
Timolol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	9.01e-05	0.00116	CcSEcCtD
Timolol—Somnolence—Formoterol—chronic obstructive pulmonary disease	9.01e-05	0.00116	CcSEcCtD
Timolol—Insomnia—Montelukast—chronic obstructive pulmonary disease	8.98e-05	0.00115	CcSEcCtD
Timolol—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	8.95e-05	0.00115	CcSEcCtD
Timolol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	8.94e-05	0.00115	CcSEcCtD
Timolol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	8.92e-05	0.00115	CcSEcCtD
Timolol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	8.92e-05	0.00115	CcSEcCtD
Timolol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	8.91e-05	0.00115	CcSEcCtD
Timolol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	8.88e-05	0.00114	CcSEcCtD
Timolol—Somnolence—Montelukast—chronic obstructive pulmonary disease	8.82e-05	0.00113	CcSEcCtD
Timolol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	8.8e-05	0.00113	CcSEcCtD
Timolol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	8.75e-05	0.00112	CcSEcCtD
Timolol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	8.75e-05	0.00112	CcSEcCtD
Timolol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	8.74e-05	0.00112	CcSEcCtD
Timolol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	8.73e-05	0.00112	CcSEcCtD
Timolol—Fatigue—Formoterol—chronic obstructive pulmonary disease	8.73e-05	0.00112	CcSEcCtD
Timolol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	8.72e-05	0.00112	CcSEcCtD
Timolol—Pain—Arformoterol—chronic obstructive pulmonary disease	8.66e-05	0.00111	CcSEcCtD
Timolol—Pain—Formoterol—chronic obstructive pulmonary disease	8.66e-05	0.00111	CcSEcCtD
Timolol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	8.65e-05	0.00111	CcSEcCtD
Timolol—Amnesia—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.00111	CcSEcCtD
Timolol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	8.59e-05	0.0011	CcSEcCtD
Timolol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	8.57e-05	0.0011	CcSEcCtD
Timolol—Fatigue—Montelukast—chronic obstructive pulmonary disease	8.56e-05	0.0011	CcSEcCtD
Timolol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	8.53e-05	0.0011	CcSEcCtD
Timolol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	8.5e-05	0.00109	CcSEcCtD
Timolol—Pain—Montelukast—chronic obstructive pulmonary disease	8.49e-05	0.00109	CcSEcCtD
Timolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	8.47e-05	0.00714	CbGpPWpGaD
Timolol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	8.46e-05	0.00109	CcSEcCtD
Timolol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	8.42e-05	0.00108	CcSEcCtD
Timolol—Rash—Aminophylline—chronic obstructive pulmonary disease	8.39e-05	0.00108	CcSEcCtD
Timolol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	8.39e-05	0.00108	CcSEcCtD
Timolol—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	8.36e-05	0.00108	CcSEcCtD
Timolol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	8.35e-05	0.00107	CcSEcCtD
Timolol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	8.35e-05	0.00107	CcSEcCtD
Timolol—Headache—Aminophylline—chronic obstructive pulmonary disease	8.34e-05	0.00107	CcSEcCtD
Timolol—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	8.32e-05	0.00107	CcSEcCtD
Timolol—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	8.31e-05	0.00107	CcSEcCtD
Timolol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	8.3e-05	0.00107	CcSEcCtD
Timolol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	8.28e-05	0.00107	CcSEcCtD
Timolol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	8.28e-05	0.00107	CcSEcCtD
Timolol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	8.26e-05	0.00106	CcSEcCtD
Timolol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	8.25e-05	0.00106	CcSEcCtD
Timolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	8.24e-05	0.00695	CbGpPWpGaD
Timolol—Pain—Salbutamol—chronic obstructive pulmonary disease	8.18e-05	0.00105	CcSEcCtD
Timolol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	8.11e-05	0.00104	CcSEcCtD
Timolol—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.00104	CcSEcCtD
Timolol—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	8.08e-05	0.00681	CbGpPWpGaD
Timolol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	8.05e-05	0.00104	CcSEcCtD
Timolol—Urticaria—Formoterol—chronic obstructive pulmonary disease	8.05e-05	0.00104	CcSEcCtD
Timolol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	8.01e-05	0.00103	CcSEcCtD
Timolol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	8.01e-05	0.00103	CcSEcCtD
Timolol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	8.01e-05	0.00103	CcSEcCtD
Timolol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	8.01e-05	0.00103	CcSEcCtD
Timolol—Affect lability—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.00103	CcSEcCtD
Timolol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	7.98e-05	0.00103	CcSEcCtD
Timolol—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	7.93e-05	0.00668	CbGpPWpGaD
Timolol—Rash—Tiotropium—chronic obstructive pulmonary disease	7.92e-05	0.00102	CcSEcCtD
Timolol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	7.91e-05	0.00102	CcSEcCtD
Timolol—Nausea—Aminophylline—chronic obstructive pulmonary disease	7.91e-05	0.00102	CcSEcCtD
Timolol—Urticaria—Montelukast—chronic obstructive pulmonary disease	7.88e-05	0.00101	CcSEcCtD
Timolol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	7.88e-05	0.00101	CcSEcCtD
Timolol—Headache—Tiotropium—chronic obstructive pulmonary disease	7.86e-05	0.00101	CcSEcCtD
Timolol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	7.86e-05	0.00101	CcSEcCtD
Timolol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	7.84e-05	0.00101	CcSEcCtD
Timolol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	7.84e-05	0.00101	CcSEcCtD
Timolol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	7.82e-05	0.00101	CcSEcCtD
Timolol—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.000992	CcSEcCtD
Timolol—Mood swings—Prednisone—chronic obstructive pulmonary disease	7.69e-05	0.000988	CcSEcCtD
Timolol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	7.6e-05	0.000977	CcSEcCtD
Timolol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	7.56e-05	0.000973	CcSEcCtD
Timolol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	7.56e-05	0.000973	CcSEcCtD
Timolol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	7.46e-05	0.00096	CcSEcCtD
Timolol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	7.46e-05	0.00096	CcSEcCtD
Timolol—Nausea—Tiotropium—chronic obstructive pulmonary disease	7.46e-05	0.000959	CcSEcCtD
Timolol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	7.44e-05	0.000957	CcSEcCtD
Timolol—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	7.43e-05	0.00626	CbGpPWpGaD
Timolol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	7.31e-05	0.00094	CcSEcCtD
Timolol—Asthenia—Formoterol—chronic obstructive pulmonary disease	7.27e-05	0.000935	CcSEcCtD
Timolol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	7.27e-05	0.000935	CcSEcCtD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	7.26e-05	0.00612	CbGpPWpGaD
Timolol—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	7.2e-05	0.00606	CbGpPWpGaD
Timolol—Pruritus—Formoterol—chronic obstructive pulmonary disease	7.17e-05	0.000922	CcSEcCtD
Timolol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	7.17e-05	0.000922	CcSEcCtD
Timolol—Asthenia—Montelukast—chronic obstructive pulmonary disease	7.12e-05	0.000916	CcSEcCtD
Timolol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	7.05e-05	0.000906	CcSEcCtD
Timolol—Pruritus—Montelukast—chronic obstructive pulmonary disease	7.02e-05	0.000903	CcSEcCtD
Timolol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	6.93e-05	0.000891	CcSEcCtD
Timolol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	6.93e-05	0.000891	CcSEcCtD
Timolol—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	6.9e-05	0.000887	CcSEcCtD
Timolol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	6.86e-05	0.000883	CcSEcCtD
Timolol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	6.79e-05	0.000873	CcSEcCtD
Timolol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	6.77e-05	0.00087	CcSEcCtD
Timolol—Erythema—Prednisolone—chronic obstructive pulmonary disease	6.72e-05	0.000865	CcSEcCtD
Timolol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	6.7e-05	0.000862	CcSEcCtD
Timolol—Dizziness—Formoterol—chronic obstructive pulmonary disease	6.7e-05	0.000862	CcSEcCtD
Timolol—Dizziness—Montelukast—chronic obstructive pulmonary disease	6.56e-05	0.000844	CcSEcCtD
Timolol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	6.55e-05	0.000842	CcSEcCtD
Timolol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	6.46e-05	0.00083	CcSEcCtD
Timolol—Vomiting—Formoterol—chronic obstructive pulmonary disease	6.44e-05	0.000828	CcSEcCtD
Timolol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	6.44e-05	0.000828	CcSEcCtD
Timolol—Rash—Formoterol—chronic obstructive pulmonary disease	6.39e-05	0.000821	CcSEcCtD
Timolol—Rash—Arformoterol—chronic obstructive pulmonary disease	6.39e-05	0.000821	CcSEcCtD
Timolol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	6.38e-05	0.000821	CcSEcCtD
Timolol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	6.38e-05	0.000821	CcSEcCtD
Timolol—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.36e-05	0.00536	CbGpPWpGaD
Timolol—Headache—Arformoterol—chronic obstructive pulmonary disease	6.35e-05	0.000816	CcSEcCtD
Timolol—Headache—Formoterol—chronic obstructive pulmonary disease	6.35e-05	0.000816	CcSEcCtD
Timolol—Weight decreased—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000816	CcSEcCtD
Timolol—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	6.34e-05	0.000815	CcSEcCtD
Timolol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	6.33e-05	0.000814	CcSEcCtD
Timolol—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000813	CcSEcCtD
Timolol—Vomiting—Montelukast—chronic obstructive pulmonary disease	6.31e-05	0.000811	CcSEcCtD
Timolol—Rash—Montelukast—chronic obstructive pulmonary disease	6.26e-05	0.000805	CcSEcCtD
Timolol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	6.25e-05	0.000804	CcSEcCtD
Timolol—Depression—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000802	CcSEcCtD
Timolol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	6.22e-05	0.00524	CbGpPWpGaD
Timolol—Headache—Montelukast—chronic obstructive pulmonary disease	6.22e-05	0.000799	CcSEcCtD
Timolol—Angioedema—Prednisolone—chronic obstructive pulmonary disease	6.14e-05	0.00079	CcSEcCtD
Timolol—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	6.14e-05	0.00517	CbGpPWpGaD
Timolol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	6.08e-05	0.000782	CcSEcCtD
Timolol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	6.04e-05	0.000777	CcSEcCtD
Timolol—Rash—Salbutamol—chronic obstructive pulmonary disease	6.03e-05	0.000776	CcSEcCtD
Timolol—Syncope—Prednisolone—chronic obstructive pulmonary disease	6.03e-05	0.000775	CcSEcCtD
Timolol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	6.03e-05	0.000775	CcSEcCtD
Timolol—Nausea—Arformoterol—chronic obstructive pulmonary disease	6.02e-05	0.000774	CcSEcCtD
Timolol—Nausea—Formoterol—chronic obstructive pulmonary disease	6.02e-05	0.000774	CcSEcCtD
Timolol—Headache—Salbutamol—chronic obstructive pulmonary disease	5.99e-05	0.000771	CcSEcCtD
Timolol—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	5.97e-05	0.00503	CbGpPWpGaD
Timolol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	5.91e-05	0.00076	CcSEcCtD
Timolol—Nausea—Montelukast—chronic obstructive pulmonary disease	5.89e-05	0.000758	CcSEcCtD
Timolol—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.85e-05	0.00493	CbGpPWpGaD
Timolol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	5.8e-05	0.000746	CcSEcCtD
Timolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	5.72e-05	0.00482	CbGpPWpGaD
Timolol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	5.71e-05	0.000735	CcSEcCtD
Timolol—Nausea—Salbutamol—chronic obstructive pulmonary disease	5.68e-05	0.000731	CcSEcCtD
Timolol—ADRB1—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	5.67e-05	0.00478	CbGpPWpGaD
Timolol—Discomfort—Prednisolone—chronic obstructive pulmonary disease	5.66e-05	0.000727	CcSEcCtD
Timolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	5.64e-05	0.00476	CbGpPWpGaD
Timolol—Hallucination—Prednisone—chronic obstructive pulmonary disease	5.58e-05	0.000718	CcSEcCtD
Timolol—ADRB2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	5.55e-05	0.00468	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	5.53e-05	0.00466	CbGpPWpGaD
Timolol—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	5.51e-05	0.000709	CcSEcCtD
Timolol—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	5.49e-05	0.00463	CbGpPWpGaD
Timolol—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	5.49e-05	0.000706	CcSEcCtD
Timolol—Oedema—Prednisolone—chronic obstructive pulmonary disease	5.49e-05	0.000706	CcSEcCtD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	5.44e-05	0.00459	CbGpPWpGaD
Timolol—Shock—Prednisolone—chronic obstructive pulmonary disease	5.4e-05	0.000694	CcSEcCtD
Timolol—ADRB2—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	5.38e-05	0.00454	CbGpPWpGaD
Timolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	5.31e-05	0.00448	CbGpPWpGaD
Timolol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	5.3e-05	0.000682	CcSEcCtD
Timolol—Eye disorder—Prednisone—chronic obstructive pulmonary disease	5.24e-05	0.000674	CcSEcCtD
Timolol—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	5.23e-05	0.0044	CbGpPWpGaD
Timolol—Angiopathy—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000655	CcSEcCtD
Timolol—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000652	CcSEcCtD
Timolol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.04e-05	0.00425	CbGpPWpGaD
Timolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	5.03e-05	0.00424	CbGpPWpGaD
Timolol—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000645	CcSEcCtD
Timolol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	4.96e-05	0.000638	CcSEcCtD
Timolol—Alopecia—Prednisone—chronic obstructive pulmonary disease	4.96e-05	0.000638	CcSEcCtD
Timolol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	4.93e-05	0.000634	CcSEcCtD
Timolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	4.92e-05	0.00414	CbGpPWpGaD
Timolol—Mental disorder—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000632	CcSEcCtD
Timolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	4.89e-05	0.00412	CbGpPWpGaD
Timolol—Malnutrition—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000628	CcSEcCtD
Timolol—Erythema—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000628	CcSEcCtD
Timolol—Pain—Prednisolone—chronic obstructive pulmonary disease	4.69e-05	0.000603	CcSEcCtD
Timolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.64e-05	0.00391	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	4.63e-05	0.0039	CbGpPWpGaD
Timolol—Vision blurred—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000592	CcSEcCtD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.55e-05	0.00384	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.53e-05	0.00381	CbGpPWpGaD
Timolol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	4.52e-05	0.000581	CcSEcCtD
Timolol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.52e-05	0.00381	CbGpPWpGaD
Timolol—Angioedema—Prednisone—chronic obstructive pulmonary disease	4.46e-05	0.000574	CcSEcCtD
Timolol—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.46e-05	0.00376	CbGpPWpGaD
Timolol—Vertigo—Prednisone—chronic obstructive pulmonary disease	4.39e-05	0.000564	CcSEcCtD
Timolol—Syncope—Prednisone—chronic obstructive pulmonary disease	4.38e-05	0.000563	CcSEcCtD
Timolol—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	4.36e-05	0.00367	CbGpPWpGaD
Timolol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	4.36e-05	0.000561	CcSEcCtD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	4.31e-05	0.00363	CbGpPWpGaD
Timolol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	4.29e-05	0.000552	CcSEcCtD
Timolol—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.22e-05	0.000542	CcSEcCtD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	4.21e-05	0.00355	CbGpPWpGaD
Timolol—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.16e-05	0.000535	CcSEcCtD
Timolol—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.16e-05	0.000535	CcSEcCtD
Timolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.16e-05	0.0035	CbGpPWpGaD
Timolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.15e-05	0.0035	CbGpPWpGaD
Timolol—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.14e-05	0.000533	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	4.13e-05	0.000531	CcSEcCtD
Timolol—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.11e-05	0.000528	CcSEcCtD
Timolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.1e-05	0.00346	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.07e-05	0.00343	CbGpPWpGaD
Timolol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.04e-05	0.00052	CcSEcCtD
Timolol—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	4e-05	0.00337	CbGpPWpGaD
Timolol—Oedema—Prednisone—chronic obstructive pulmonary disease	3.99e-05	0.000513	CcSEcCtD
Timolol—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	3.99e-05	0.000513	CcSEcCtD
Timolol—Infection—Prednisone—chronic obstructive pulmonary disease	3.96e-05	0.000509	CcSEcCtD
Timolol—Shock—Prednisone—chronic obstructive pulmonary disease	3.92e-05	0.000504	CcSEcCtD
Timolol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	3.91e-05	0.000503	CcSEcCtD
Timolol—ADRB3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.87e-05	0.00326	CbGpPWpGaD
Timolol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000498	CcSEcCtD
Timolol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	3.85e-05	0.000496	CcSEcCtD
Timolol—Anorexia—Prednisone—chronic obstructive pulmonary disease	3.8e-05	0.000489	CcSEcCtD
Timolol—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	3.73e-05	0.00315	CbGpPWpGaD
Timolol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.66e-05	0.00309	CbGpPWpGaD
Timolol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	3.63e-05	0.000467	CcSEcCtD
Timolol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	3.63e-05	0.000467	CcSEcCtD
Timolol—Insomnia—Prednisone—chronic obstructive pulmonary disease	3.61e-05	0.000464	CcSEcCtD
Timolol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	3.58e-05	0.00046	CcSEcCtD
Timolol—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	3.57e-05	0.00301	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.56e-05	0.003	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	3.55e-05	0.00299	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.52e-05	0.00296	CbGpPWpGaD
Timolol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	3.51e-05	0.000451	CcSEcCtD
Timolol—ADRB3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.47e-05	0.00292	CbGpPWpGaD
Timolol—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	3.47e-05	0.000446	CcSEcCtD
Timolol—Rash—Prednisolone—chronic obstructive pulmonary disease	3.46e-05	0.000445	CcSEcCtD
Timolol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	3.46e-05	0.000444	CcSEcCtD
Timolol—Fatigue—Prednisone—chronic obstructive pulmonary disease	3.44e-05	0.000442	CcSEcCtD
Timolol—Headache—Prednisolone—chronic obstructive pulmonary disease	3.44e-05	0.000442	CcSEcCtD
Timolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.37e-05	0.00284	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	3.3e-05	0.00278	CbGpPWpGaD
Timolol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.29e-05	0.000423	CcSEcCtD
Timolol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.28e-05	0.00276	CbGpPWpGaD
Timolol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.26e-05	0.000419	CcSEcCtD
Timolol—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.26e-05	0.000419	CcSEcCtD
Timolol—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.22e-05	0.00271	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.21e-05	0.0027	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.19e-05	0.00268	CbGpPWpGaD
Timolol—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.17e-05	0.000407	CcSEcCtD
Timolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.15e-05	0.00266	CbGpPWpGaD
Timolol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.15e-05	0.000405	CcSEcCtD
Timolol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.15e-05	0.000405	CcSEcCtD
Timolol—ADRB3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.12e-05	0.00263	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.1e-05	0.00261	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.96e-05	0.0025	CbGpPWpGaD
Timolol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.94e-05	0.000378	CcSEcCtD
Timolol—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.93e-05	0.00247	CbGpPWpGaD
Timolol—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.86e-05	0.000368	CcSEcCtD
Timolol—ADRB3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.84e-05	0.00239	CbGpPWpGaD
Timolol—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.82e-05	0.000363	CcSEcCtD
Timolol—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	2.78e-05	0.00234	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.74e-05	0.00231	CbGpPWpGaD
Timolol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.73e-05	0.000351	CcSEcCtD
Timolol—ADRB3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.71e-05	0.00228	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.7e-05	0.00228	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.69e-05	0.00226	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.68e-05	0.00226	CbGpPWpGaD
Timolol—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.64e-05	0.00223	CbGpPWpGaD
Timolol—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.64e-05	0.000339	CcSEcCtD
Timolol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.63e-05	0.00221	CbGpPWpGaD
Timolol—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.54e-05	0.000326	CcSEcCtD
Timolol—Rash—Prednisone—chronic obstructive pulmonary disease	2.51e-05	0.000323	CcSEcCtD
Timolol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.51e-05	0.000323	CcSEcCtD
Timolol—Headache—Prednisone—chronic obstructive pulmonary disease	2.5e-05	0.000321	CcSEcCtD
Timolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.47e-05	0.00208	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.46e-05	0.00208	CbGpPWpGaD
Timolol—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.43e-05	0.00205	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.41e-05	0.00203	CbGpPWpGaD
Timolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.41e-05	0.00203	CbGpPWpGaD
Timolol—Nausea—Prednisone—chronic obstructive pulmonary disease	2.37e-05	0.000305	CcSEcCtD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.36e-05	0.00199	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.3e-05	0.00194	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.26e-05	0.00191	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.25e-05	0.0019	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.23e-05	0.00188	CbGpPWpGaD
Timolol—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.2e-05	0.00186	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.2e-05	0.00185	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.11e-05	0.00178	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.09e-05	0.00176	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.08e-05	0.00175	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.07e-05	0.00174	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.06e-05	0.00173	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.05e-05	0.00173	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.05e-05	0.00173	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.04e-05	0.00172	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	2.04e-05	0.00172	CbGpPWpGaD
Timolol—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.03e-05	0.00171	CbGpPWpGaD
Timolol—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.02e-05	0.00171	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.96e-05	0.00165	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	1.96e-05	0.00165	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.95e-05	0.00164	CbGpPWpGaD
Timolol—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.92e-05	0.00162	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	1.91e-05	0.00161	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.89e-05	0.00159	CbGpPWpGaD
Timolol—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.86e-05	0.00157	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.85e-05	0.00156	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.84e-05	0.00155	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.81e-05	0.00153	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.8e-05	0.00152	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.00151	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.78e-05	0.0015	CbGpPWpGaD
Timolol—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.77e-05	0.00149	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.75e-05	0.00148	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.68e-05	0.00142	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.68e-05	0.00141	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.67e-05	0.00141	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	1.66e-05	0.0014	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.65e-05	0.00139	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.63e-05	0.00137	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.61e-05	0.00136	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.59e-05	0.00134	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.59e-05	0.00134	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.57e-05	0.00133	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	1.57e-05	0.00132	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.53e-05	0.00129	CbGpPWpGaD
Timolol—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	1.53e-05	0.00129	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	1.52e-05	0.00128	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.44e-05	0.00121	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	1.42e-05	0.0012	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.39e-05	0.00117	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.31e-05	0.0011	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.28e-05	0.00108	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.23e-05	0.00104	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.23e-05	0.00103	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.21e-05	0.00102	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.16e-05	0.00098	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.14e-05	0.00096	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.00094	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.06e-05	0.00089	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.000886	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.04e-05	0.000876	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.04e-05	0.000874	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	0.000866	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.02e-05	0.000857	CbGpPWpGaD
Timolol—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.01e-05	0.000853	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.01e-05	0.00085	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.94e-06	0.000838	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.94e-06	0.000837	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	9.85e-06	0.00083	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.73e-06	0.00082	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.72e-06	0.000819	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.54e-06	0.000804	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.46e-06	0.000797	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.44e-06	0.000795	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.39e-06	0.000791	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.38e-06	0.00079	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	9.28e-06	0.000782	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.23e-06	0.000778	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.15e-06	0.000771	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.09e-06	0.000766	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.89e-06	0.000749	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.63e-06	0.000727	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.59e-06	0.000724	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.54e-06	0.000719	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.26e-06	0.000696	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.22e-06	0.000692	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	8.18e-06	0.000689	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.08e-06	0.00068	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.85e-06	0.000661	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.64e-06	0.000644	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	7.51e-06	0.000633	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.47e-06	0.00063	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.36e-06	0.00062	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.27e-06	0.000613	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.11e-06	0.000599	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.01e-06	0.000591	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.76e-06	0.00057	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.61e-06	0.000557	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.28e-06	0.000529	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.24e-06	0.000526	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.18e-06	0.000521	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.99e-06	0.000505	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.72e-06	0.000482	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.62e-06	0.000473	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.57e-06	0.00047	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.51e-06	0.000464	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.49e-06	0.000463	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.45e-06	0.000459	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	5.45e-06	0.000459	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.38e-06	0.000453	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.32e-06	0.000448	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.1e-06	0.00043	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.08e-06	0.000428	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.08e-06	0.000428	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.07e-06	0.000427	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.07e-06	0.000427	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.01e-06	0.000422	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.99e-06	0.00042	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	4.97e-06	0.000419	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.96e-06	0.000418	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.88e-06	0.000411	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.85e-06	0.000409	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.83e-06	0.000407	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.77e-06	0.000402	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.71e-06	0.000397	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.59e-06	0.000387	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.58e-06	0.000386	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.57e-06	0.000385	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.53e-06	0.000382	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.47e-06	0.000377	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.44e-06	0.000374	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.21e-06	0.000355	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.12e-06	0.000347	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.82e-06	0.000322	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.78e-06	0.000319	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.77e-06	0.000317	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.73e-06	0.000314	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.73e-06	0.000314	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.71e-06	0.000313	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.68e-06	0.00031	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.65e-06	0.000307	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.56e-06	0.0003	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.51e-06	0.000296	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.51e-06	0.000296	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.48e-06	0.000293	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.46e-06	0.000292	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.43e-06	0.000289	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.4e-06	0.000286	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.33e-06	0.00028	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.32e-06	0.00028	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.25e-06	0.000274	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.23e-06	0.000272	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.12e-06	0.000262	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.06e-06	0.000258	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.01e-06	0.000254	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.95e-06	0.000248	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.87e-06	0.000241	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.85e-06	0.00024	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.8e-06	0.000236	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.73e-06	0.00023	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.67e-06	0.000225	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.45e-06	0.000206	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.39e-06	0.000202	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	2.26e-06	0.000191	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.25e-06	0.000189	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.21e-06	0.000186	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.2e-06	0.000186	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.2e-06	0.000185	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.16e-06	0.000182	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.15e-06	0.000182	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.11e-06	0.000178	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.08e-06	0.000175	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.99e-06	0.000168	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.85e-06	0.000156	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.81e-06	0.000152	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.69e-06	0.000143	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.66e-06	0.000139	CbGpPWpGaD
